Control of the of the final stage of immune-mediated diabetes by ISO-1, an antagonist of macrophage migration inhibitory factor
We recently showed that attenuation of inflammatory cytokine MIF with pharmacological inhibitor ISO-1 down-regulates the immune-mediated diabetes in mice. Here we explore the effects of MIF neutralization by ISO-1 on the local inflammatory pathway of the disease. In vivo treatment of mice with ISO-1...
Main Authors: | Stojanović Ivana, Maksimović-Ivanić Danijela, Al-Abed Y., Nicoletti F., Stošić-Grujičić Stanislava |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Belgrade, University of Novi Sad
2008-01-01
|
Series: | Archives of Biological Sciences |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-4664/2008/0354-46640803389S.pdf |
Similar Items
-
Deficiency of macrophage migration inhibitory factor (MIF) inhibits cytokine-induced IL-1β generation in murine pancreatic islet cells
by: Stojanović Ivana, et al.
Published: (2013-01-01) -
Synthesis and characterization of new 3-(4,5-dihydro-5-aryl)isoxazol-3-yl)-4-hydroxyquinolin-2(1H)-ones and 3-(4-styryl)isoxazolo[4,5-c]quinolin-4(5H)-one derivatives
by: S. Sarveswari, et al.
Published: (2016-09-01) -
6-Phenyl-2-(4-phenyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4,5-dihydropyridazin-3(2H)-one
by: Mohammad Shaharyar, et al.
Published: (2010-10-01) -
Pathogenetic Therapy of Psoriasis by Muramyl Peptide
by: Svetlana Guryanova, et al.
Published: (2019-06-01) -
DMBT1 has a protective effect on allergic rhinitis
by: Yu Zhao, et al.
Published: (2020-01-01)